IFP Advisors’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$64 Hold
9
– – ﹤0.01% 5032
2026
Q2
$221 Hold
9
– – ﹤0.01% 4843
2026
Q1
$157 Hold
9
– – ﹤0.01% 4660
2025
Q4
$119 Buy
9
+7
+350% +$62 ﹤0.01% 4562
2025
Q3
$12 Buy
+2
New +$9 ﹤0.01% 4781

Other funds holding BIOA

IFP Advisors's BIOA Position: Q3 2026 in Review

IFP Advisors held its BioAge Labs (BIOA) position steady in Q3 2026 at 9 shares worth $64. The position accounts for ﹤0.01% of the portfolio, ranked #5032.

IFP Advisors first reported a position in BIOA in Q3 2025 and has held it in 5 quarters since. The position peaked at $221 in Q2 2026. 45 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • IFP Advisors held 9 shares of BioAge Labs worth $64 as of Q3 2026.
  • IFP Advisors left its BioAge Labs share count unchanged in Q3 2026.
  • BioAge Labs made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5032 holding.
  • IFP Advisors first reported a position in BioAge Labs in Q3 2025 and has held it in 5 quarters since.
  • IFP Advisors's BioAge Labs position peaked at $221 in Q2 2026.
  • 45 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.